Yu Wang

Yu Wang

Chief Tech/Sci/R&D Officer at GENFLEET THERAPEUTICS (SHANGHAI) INC.
Health Technology
Consumer Services

Profile

Yu Wang is currently the Chief Medical Officer at Genfleet Therapeutics (Shanghai), Inc. and Abbisko Therapeutics Co., Ltd. He previously worked as the Director-Associate Medical at Eli Lilly Asia, Inc. from 2007 to 2010, Director-Medical at GlaxoSmithKline (China) Investment Co., Ltd. from 2010 to 2012, Director-Clinical Research at Sanofi (China) Investment Co. Ltd. from 2012 to 2013, Senior Research Member at Shanghai Sunway Biotech Co., Ltd. from 2005 to 2007, Partner at Zenrhyme Consulting Services Co. Ltd. from 2018 to 2020, and Chief Scientist Officer at Beijing Panacro Pharmaceutical Technology Co. Ltd. from 2016 to 2017.
Dr. Wang obtained a doctorate degree from Shanghai Medical College of Fudan University in 2000 and an undergraduate degree from Tongji Medical College of Huazhong University of Sci & Tech in 1995.

Yu Wang active positions

CompaniesPositionStart
GENFLEET THERAPEUTICS (SHANGHAI) INC. Chief Tech/Sci/R&D Officer 2020-10-31
Chief Tech/Sci/R&D Officer 2020-02-29

Former positions of Yu Wang

CompaniesPositionEnd
Corporate Officer/Principal 2013-08-31
Chief Tech/Sci/R&D Officer 2012-02-29
Eli Lilly Asia, Inc.
Chief Tech/Sci/R&D Officer 2010-01-31
See the detail of Yu Wang's experience

Training of Yu Wang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Eli Lilly Asia, Inc.

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!